McKesson Basic EPS 2010-2024 | MCK
McKesson annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- McKesson basic eps for the quarter ending December 31, 2024 was $6.95, a 57.24% increase year-over-year.
- McKesson basic eps for the twelve months ending December 31, 2024 was $21.97, a 0.9% decline year-over-year.
- McKesson annual basic eps for 2024 was $0.023B, a 10.66% decline from 2023.
- McKesson annual basic eps for 2023 was $0.025B, a 244.67% increase from 2022.
- McKesson annual basic eps for 2022 was $0.007B, a 125.9% decline from 2021.
| McKesson Annual Basic EPS |
| 2024 |
$22.54 |
| 2023 |
$25.23 |
| 2022 |
$7.32 |
| 2021 |
$-28.26 |
| 2020 |
$4.98 |
| 2019 |
$0.17 |
| 2018 |
$0.32 |
| 2017 |
$22.95 |
| 2016 |
$9.82 |
| 2015 |
$6.37 |
| 2014 |
$5.51 |
| 2013 |
$5.71 |
| 2012 |
$5.70 |
| 2011 |
$4.65 |
| 2010 |
$4.70 |
| 2009 |
$2.99 |
| McKesson Quarterly Basic EPS |
| 2024-12-31 |
$6.95 |
| 2024-09-30 |
$1.88 |
| 2024-06-30 |
$7.04 |
| 2024-03-31 |
$6.10 |
| 2023-12-31 |
$4.42 |
| 2023-09-30 |
$4.95 |
| 2023-06-30 |
$7.07 |
| 2023-03-31 |
$5.73 |
| 2022-12-31 |
$7.71 |
| 2022-09-30 |
$6.47 |
| 2022-06-30 |
$5.32 |
| 2022-03-31 |
$2.52 |
| 2021-12-31 |
$-0.04 |
| 2021-09-30 |
$1.73 |
| 2021-06-30 |
$3.11 |
| 2021-03-31 |
$4.47 |
| 2020-12-31 |
$-39.03 |
| 2020-09-30 |
$3.56 |
| 2020-06-30 |
$2.74 |
| 2020-03-31 |
$5.68 |
| 2019-12-31 |
$1.04 |
| 2019-09-30 |
$-3.99 |
| 2019-06-30 |
$2.25 |
| 2019-03-31 |
$-4.08 |
| 2018-12-31 |
$2.41 |
| 2018-09-30 |
$2.52 |
| 2018-06-30 |
$-0.68 |
| 2018-03-31 |
$-5.50 |
| 2017-12-31 |
$4.35 |
| 2017-09-30 |
$0.01 |
| 2017-06-30 |
$1.46 |
| 2017-03-31 |
$16.31 |
| 2016-12-31 |
$2.87 |
| 2016-09-30 |
$1.36 |
| 2016-06-30 |
$2.41 |
| 2016-03-31 |
$1.91 |
| 2015-12-31 |
$2.76 |
| 2015-09-30 |
$2.66 |
| 2015-06-30 |
$2.49 |
| 2015-03-31 |
$0.57 |
| 2014-12-31 |
$2.03 |
| 2014-09-30 |
$2.02 |
| 2014-06-30 |
$1.75 |
| 2014-03-31 |
$1.61 |
| 2013-12-31 |
$0.28 |
| 2013-09-30 |
$1.76 |
| 2013-06-30 |
$1.86 |
| 2013-03-31 |
$1.13 |
| 2012-12-31 |
$1.27 |
| 2012-09-30 |
$1.70 |
| 2012-06-30 |
$1.61 |
| 2012-03-31 |
$2.13 |
| 2011-12-31 |
$1.22 |
| 2011-09-30 |
$1.20 |
| 2011-06-30 |
$1.15 |
| 2011-03-31 |
$1.65 |
| 2010-12-31 |
$0.61 |
| 2010-09-30 |
$1.27 |
| 2010-06-30 |
$1.12 |
| 2010-03-31 |
$1.29 |
| 2009-12-31 |
$1.21 |
| 2009-09-30 |
$1.13 |
| 2009-06-30 |
$1.07 |
| 2009-03-31 |
$1.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED/DENTAL-SUPP |
$88.782B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
